Bioactivity of Cyperus amuricus extracts against hepatocellular carcinoma and molecular docking analysis targeting the PI3K/AKT/mTOR pathway
PLOS One · 2026
DOI: 10.1371/journal.pone.0340868 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Thanh Luan Nguyen und 6 weiteren Autor:innen. Beteiligte Einrichtung: HUTECH Institute of Applied Science, HUTECH University, Ho Chi Minh City, Vietnam. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Carcinoma, Hepatocellular, TOR Serine-Threonine Kinases, Liver Neoplasms. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vietnam National Foundation for Science and Technology Development, Nguyen Tat Thanh University, Ho Chi Minh City, Vietnam.
Abstract (Originalsprache)
Cyperus amuricus (Cyperaceae) has exhibited potential anticancer activity against hepatocellular carcinoma (HCC), yet its molecular mechanisms and phytoconstituent interactions with oncogenic pathways remain underexplored. This study integrates in vitro cytotoxicity assays and molecular docking to evaluate the effects of C. amuricus fractionated extracts on HCC, focusing on PI3K/AKT/mTOR signaling axis. The ethyl acetate (EA) fraction selectively inhibited HepG2 cell proliferation (IC 50 = 159.76 µg/mL) with minimal toxicity to normal fibroblasts. Apoptotic features—cell shrinkage, membrane blebbing, nuclear condensation, and DNA fragmentation—were confirmed through DAPI staining and gel electrophoresis. Western blot analysis revealed dose-dependent suppression of phosphorylated Akt and p70S6K, indicating pathway inhibition. Molecular docking identified strong binding affinities between Cyperaceae-derived compounds and PI3K/AKT/mTOR targets, with luteolin 7-O-β-D-glucuronopyranoside-6″-methyl ester blocked PI3K activation, vitexin bound AKT’s allosteric site, and digitoxin targeted mTOR’s ATP-binding pocket, showing comparable binding energies to reference ligands. These findings suggest C. amuricus as a promising candidate for natural product-based HCC therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- HUTECH Institute of Applied Science, HUTECH University, Ho Chi Minh City, Vietnam.
- Center for Hi-Tech Development, Nguyen Tat Thanh University, Saigon Hi-Tech Park, Ho Chi Minh City, Vietnam.
- NTT Hi-Tech Institute, Nguyen Tat Thanh University, Ho Chi Minh City, Vietnam.
- Faculty of Pharmacy, Nguyen Tat Thanh University, Ho Chi Minh City, Vietnam.
- Institute of Applied Science and Technology, Van Lang School of Technology, Van Lang University, Ho Chi Minh City, Vietnam.
- Faculty of Applied Technology, Van Lang School of Technology, Van Lang University, Ho Chi Minh City, Vietnam.
ORCID-Profile: Minh Quan Pham, Hai Ha Pham Thi
Förderung
- Vietnam National Foundation for Science and Technology Development
- Nguyen Tat Thanh University, Ho Chi Minh City, Vietnam
Zitieren
APA
Nguyen, T. L., Tu, T. K., Phan, T. V., Nguyen, C. M., Nguyen, K. D., Pham, M. Q., & Pham Thi, H. H. (2026). Bioactivity of Cyperus amuricus extracts against hepatocellular carcinoma and molecular docking analysis targeting the PI3K/AKT/mTOR pathway. PLOS One. https://doi.org/10.1371/journal.pone.0340868
Vancouver
Nguyen TL, Tu TK, Phan TV, Nguyen CM, Nguyen KD, Pham MQ, et al. Bioactivity of Cyperus amuricus extracts against hepatocellular carcinoma and molecular docking analysis targeting the PI3K/AKT/mTOR pathway. PLOS One. 2026. doi:10.1371/journal.pone.0340868
BibTeX
@article{Nguyen2026,
author = {Nguyen, Thanh Luan and Tu, Thanh Khoi and Phan, Thien-Vy and Nguyen, Chanh M and Nguyen, Khoa D and Pham, Minh Quan and Pham Thi, Hai Ha},
title = {Bioactivity of Cyperus amuricus extracts against hepatocellular carcinoma and molecular docking analysis targeting the PI3K/AKT/mTOR pathway},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0340868}
}
EUVIMED